NGS-HPC: Hereditary predisposition to prostate cancer: Identification of heritability by discovering by combining exome sequencing and haplotype analysis in a population with strong effect (Q2906214): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 166,625.5 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 01:28, 5 November 2022
Project Q2906214 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NGS-HPC: Hereditary predisposition to prostate cancer: Identification of heritability by discovering by combining exome sequencing and haplotype analysis in a population with strong effect |
Project Q2906214 in Portugal |
Statements
166,625.5 Euro
0 references
196,030.0 Euro
0 references
85.0 percent
0 references
1 July 2016
0 references
1 July 2019
0 references
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
0 references
Q2997125 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016889
0 references